THE COVID-19 PANDEMIC AND INDIAN PHARMACEUTICAL COMPANIES: AN EVENT STUDY ANALYSIS

  • Chinmaya Behera Goa Institute of Management
  • Badri Narayan Rath IIT Hyderabad, India.
Keywords: COVID-19, Pharmaceutical companies, Risk, Stock return, Event study analysis

Abstract

Although there is a plethora of studies which examine the impact of the COVID-19 pandemic on India’s financial sector, we contribute by investigating the effect of the ongoing COVID-19 pandemic on stock returns of Indian pharmaceutical companies. By employing an event study methodology, our results indicate that the average returns of the pharmaceutical sector are positive during the COVID-19 phase although
mixed evidence is found at the firm level. This finding is also robust to alternative model specifications.

 

 

Downloads

Download data is not yet available.

References

Agarwalla, S. K., Jacob, J., & Varma, J. R. (2013). Four Factor Model in Indian Equities Market. (Working Paper W.P. No. 2013-09-05). Indian Institute of Management, Ahmedabad.

Athreye, S., & Godley, A. (2009). Internationalization and Technological Leapfrogging in the Pharmaceutical Industry. Industrial and Corporate Change, 18, 295-323.

Dev, S. M., & Sengupta, R. (2020). Covid-19: Impact on the Indian Economy (Indira Gandhi Institute of Development Research Working Paper, No.2020-013). Indira Gandhi Institute of Development.

Devpura, N. (2020). Can Oil Prices Predict Japanese Yen? Asian Economics Letters, 1(3). https://doi.org/10.46557/001c.17964

Devpura, N., & Narayan, P.K. (2020) Hourly Oil Price Volatility: The Role of COVID-19. Energy Research Letters, 1, 13683. https://doi.org/10.46557/001c.13683

Donadelli, M., Kizys, R., & Riedel, M. (2017). Dangerous Infectious Diseases: Bad News for Main Street, Good News for Wall Street? Journal of Financial Markets, 35, 84-103.

Fama, Eugene F., & French. Kenneth R. (1993). Common Risk Factors in the Returns on Stocks and Bonds. Journal of Financial Economics, 33, 1, 3–56.

Gu, X., Ying, S., Zhang, W., & Tao, Y. (2020). How do Firms Respond to COVID-19? First Evidence from Suzhou, China. Emerging Markets Finance and Trade, 56, 2181-2197.

He, P., Sun, Y., Zhang, Y., & Li, T. (2020). COVID-19’s Impact on Stock Prices Across Different Sectors—An Event Study Based on the Chinese Stock Market. Emerging Markets Finance and Trade, 56, 2198-2212. https://doi.org/10.1080/1540496X.2020.1785865.

He, P., Niu, H., Sun, Z., & Li, T. (2020) Accounting Index of COVID-19 Impact on Chinese Industries: A Case Study Using Big Data Portrait Analysis. Emerging Markets Finance and Trade, 56, 2332-2349. https://doi.org/10.1080/1540496X.2020.1785866

Iyke, N. B. (2020). Economic Policy Uncertainty in Times of COVID-19 Pandemic. Asian Economics Letters, 1. https://doi.org/10.46557/001c.17665

Kale, D. (2019). From Small Molecule Generics to Biosimilars: Technological Upgrading and Patterns of Distinctive Learning Processes in the Indian Pharmaceutical Industry. Technological Forecasting and Social Change, 145, 370-383.

Kale, D., & Little, S. (2007). From Imitation to Innovation: The Evolution of R&D Capabilities and Learning Processes in the Indian Pharmaceutical Industry. Technology Analysis & Strategic Management, 19, 589-609.

Kritzman, M. P. (1994). What Practitioners Need to Know About Event Studies. Financial Analysts Journal, 50, 17-20.

Mishra, A.K., Rath, B.N., & Dash, A.K. (2020) Does the Indian Financial Market Nosedive Because of the COVID-19 Outbreak, in Comparison to After Demonetisation and the GST? Emerging Markets Finance and Trade, 56, 2162-

Narayan, P. K. (2020a). Oil price news and COVID-19—Is There Any Connection? Energy Research Letters, 1, 13176. https://doi.org/10.46557/001c.13176

Narayan, P. K. (2020b). Did Bubble Activity Intensify During COVID-19? Asian Economics Letters, 1(2). https://doi.org/10.46557/001c.17654

Narayan, P. K. (2020c). Has COVID-19 Changed Exchange Rate Resistance to Shocks? Asian Economics Letters, 1. https://doi.org/10.46557/001c.17389

Narayan, P. K., Phan, D. H. B., & Bannigidadmath, D. (2017). Is the Profitability of Indian Stocks Compensation for Risks? Emerging Markets Review, 31, 47-64.

Narayan, P. K., Ranjeeni, K., & Bannigidadmath, D. (2017). New Evidence of Psychological Barrier from the Oil Market. Journal of Behavioral Finance, 18,457-469.

Phan, D.H.B., & Narayan, P.K. (2020) Country responses and the reaction of the stock market to COVID-19—a Preliminary Exposition. Emerging Markets Finance and Trade; 56(10), 2138-2150. https://doi.org/10.1080/1540496X.2020.1784719

Prabheesh, K.P. (2020). Dynamics of Foreign Portfolio Investment and Stock Market Returns During the COVID-19 Pandemic: Evidence from India. Asian Economics Letters, 1. https://doi.org/10.46557/ 001c.17658.

Ramelli, S., & Wagner, A. F. (2020). Feverish Stock Price Reactions to COVID-19 (CEPR Discussion Papers, 14511). C.E.P.R.

Rath, B.N., & Akram, V. (2020). Does COVID‐19 Outbreak Cause Spot Electricity Price Discovery in India? Journal of Public Affairs. https://doi.org/10.1002/pa.2439.

Seungho, B., Mohanty, S.K., & Glambosky, M. (2020). COVID-19 and Stock Market Volatility: An Industry Level Analysis. Finance Research Letters, 37, 101748.

Sha, Y., & Sharma, S.S. (2020) Research on Pandemics Special Issue of the Journal Emerging Markets Finance and Trade, 56, 2133-2137; https://doi.org/10.1080/1540496X.2020.1795467

Sharma, C. (2012). R&D and Productivity in the Indian Pharmaceutical Firms. Journal of the Asia Pacific Economy, 17, 332-342.

Sharma, S. S. (2020). A Note on the Asian Market Volatility During the COVID-19 Pandemic. Asian Economics Letters, 1. https://doi.org/10.46557/001c.17661

Sharma, S.S., & Sha, Y. (2020) Part A: Special Section on COVID-19 Research. Emerging Markets Finance and Trade, 56, 3551-3553. https://doi.org/10.1080/1540496X.2020.1858617

Shen, H., Fu, M., Pan, H., Yu, Z., & Chen, Y. (2020). The Impact of the COVID-19 Pandemic on Firm Performance. Emerging Markets Finance and Trade, 56, 2213-2230.

Yan, C. (2020). COVID-19 Outbreak and Stock Prices: Evidence from China. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3574374.

Published
2021-03-08
How to Cite
Behera, C., & Rath, B. (2021). THE COVID-19 PANDEMIC AND INDIAN PHARMACEUTICAL COMPANIES: AN EVENT STUDY ANALYSIS. Buletin Ekonomi Moneter Dan Perbankan, 24, 1-14. https://doi.org/10.21098/bemp.v24i0.1483